GLP Watchdog

CoreAge Rx vs RxSpan MD

Neither CoreAge Rx nor RxSpan MD has an FDA warning letter on record. On compounded tirzepatide injection, CoreAge Rx costs $2,400 less a year at standing rates: $129 a month against $329 a month at RxSpan MD. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

CoreAge Rx / RxSpan MD

CoreAge Rx logo

CoreAge Rx

9.0/10

RxSpan MD logo

RxSpan MD

7.9/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$79/moCompounded semaglutide injection
$249/moCompounded semaglutide injection
States
48 states
All 50 states
Checked
Prices captured Record checked November 2026
Prices captured Record checked October 2026
Visit CoreAge Rx
Visit RxSpan MD

Both CoreAge Rx and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (CoreAge Rx 9.0, RxSpan MD 7.9). How we are paid

What the record shows

  1. 01

    Neither CoreAge Rx nor RxSpan MD has an FDA warning letter on record.

  2. 02

    RxSpan MD names four pharmacies. CoreAge Rx names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, CoreAge Rx costs $2,400 less a year at standing rates: $129 a month against $329 a month at RxSpan MD. It is one of two products the two sell at comparable terms.

  4. 04

    Only RxSpan MD lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    RxSpan MD covers two states CoreAge Rx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

CoreAge Rx

RxSpan MD

Compounded semaglutide injection

$79/moLower

$948 a year

$249/mo

$2,988 a year

Compounded tirzepatide injection

$129/moLower

$1,548 a year

$329/mo

$3,948 a year

Brand-name semaglutide pen
Not sold or not priced

$1,299/mo

$15,588 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,069/mo

$12,828 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None
Refunds
Refund before provider approval, less a $50-$100 consult fee; final once sent to the pharmacy; none after 30 days
Not stated
Early-exit fee
None stated
None stated

Read off each seller’s own pages. CoreAge Rx: November 5, 2026. RxSpan MD: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for CoreAge Rx

9.0/10
  • $2,040 a year less on compounded semaglutide injection
  • $2,400 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit CoreAge Rx

The case for RxSpan MD

7.9/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which CoreAge Rx does not price
  • Names its compounding pharmacy
Visit RxSpan MD

Scores

CoreAge Rx 9.0 · RxSpan MD 7.9 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.5

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
10.0

Accessibility10%

9.7A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

The score is the same formula for every seller. Payment does not enter it. Method

CoreAge Rx vs RxSpan MD: questions

Neither CoreAge Rx nor RxSpan MD has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
RxSpan MD names four pharmacies. CoreAge Rx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
CoreAge Rx, by $2,040 a year at standing rates. CoreAge Rx: $79 a month, about $948 a year. RxSpan MD: $249 a month, about $2,988 a year.
CoreAge Rx states you can cancel at any time; refunds: refund before provider approval, less a $50-$100 consult fee; final once sent to the pharmacy; none after 30 days. RxSpan MD states you can cancel at any time.
Both CoreAge Rx and RxSpan MD are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (CoreAge Rx 9.0, RxSpan MD 7.9).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks